Cargando…
Potent antiviral agent WIN 54954: high specific activity labelling with tritium
Valuable antiviral compound WIN 54954 (2) was tritiated at high specific activity and the product was characterized.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127203/ https://www.ncbi.nlm.nih.gov/pubmed/15110350 http://dx.doi.org/10.1016/j.apradiso.2004.03.002 |
| _version_ | 1783516309307260928 |
|---|---|
| author | Egan, Judith A. Nugent, Richard P. Filer, Crist N. |
| author_facet | Egan, Judith A. Nugent, Richard P. Filer, Crist N. |
| author_sort | Egan, Judith A. |
| collection | PubMed |
| description | Valuable antiviral compound WIN 54954 (2) was tritiated at high specific activity and the product was characterized. |
| format | Online Article Text |
| id | pubmed-7127203 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2004 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71272032020-04-08 Potent antiviral agent WIN 54954: high specific activity labelling with tritium Egan, Judith A. Nugent, Richard P. Filer, Crist N. Appl Radiat Isot Article Valuable antiviral compound WIN 54954 (2) was tritiated at high specific activity and the product was characterized. Elsevier Ltd. 2004-06 2004-04-15 /pmc/articles/PMC7127203/ /pubmed/15110350 http://dx.doi.org/10.1016/j.apradiso.2004.03.002 Text en Copyright © 2004 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Egan, Judith A. Nugent, Richard P. Filer, Crist N. Potent antiviral agent WIN 54954: high specific activity labelling with tritium |
| title | Potent antiviral agent WIN 54954: high specific activity labelling with tritium |
| title_full | Potent antiviral agent WIN 54954: high specific activity labelling with tritium |
| title_fullStr | Potent antiviral agent WIN 54954: high specific activity labelling with tritium |
| title_full_unstemmed | Potent antiviral agent WIN 54954: high specific activity labelling with tritium |
| title_short | Potent antiviral agent WIN 54954: high specific activity labelling with tritium |
| title_sort | potent antiviral agent win 54954: high specific activity labelling with tritium |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127203/ https://www.ncbi.nlm.nih.gov/pubmed/15110350 http://dx.doi.org/10.1016/j.apradiso.2004.03.002 |
| work_keys_str_mv | AT eganjuditha potentantiviralagentwin54954highspecificactivitylabellingwithtritium AT nugentrichardp potentantiviralagentwin54954highspecificactivitylabellingwithtritium AT filercristn potentantiviralagentwin54954highspecificactivitylabellingwithtritium |